CCI study supports renal denervation for milder hypertension

05/24/2013 | Cardiology Today's Intervention magazine

Data from a pilot study published in Catheterization and Cardiovascular Interventions suggest renal denervation is safe and effective for treatment of mild resistant hypertension, findings that "[expand] the potential boundaries for renal denervation," according to an accompanying editorial by SCAI fellow Dr. Deepak Bhatt. No adverse events were documented in the study of 20 patients, while four were able to scale back antihypertensive therapies by the three-month follow-up.

View Full Article in:

Cardiology Today's Intervention magazine

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY